Med-tech start-up 52 North Health has raised 拢1 million in its first round of funding to help it develop the NeutroCheck, a fully-integrated clinical...
Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of...
Cambridge spin-out Zetta Genomics has raised 拢2.5 million in new seed funding from Nina Capital, APEX Medical and Cambridge Enterprise to advance its...